GO:1903697 negative regulation of microvillus assembly

Microvilli are actin-rich, finger-like protrusions of the apical plasma membrane that increase surface area for absorption and secretion in epithelial cells. Their assembly is a highly regulated process that requires coordinated actin polymerization, bundling, and membrane anchoring, primarily through the ezrin-radixin-moesin (ERM) family of proteins and Rho GTPase signaling. The Gene Ontology term GO:1903697, negative regulation of microvillus assembly, refers to any process that stops, prevents, or reduces the frequency, rate, or extent of microvillus assembly. This regulatory process is essential for maintaining epithelial architecture and function, and its dysregulation has been implicated in various diseases, including cancer and inflammatory conditions. Researchers study negative regulation of microvillus assembly to understand how cells control apical membrane dynamics during development, tissue homeostasis, and disease. For example, cyclic AMP-dependent protein kinase A (PKA) has been shown to negatively modulate adherens junction integrity and differentiation of intestinal epithelial cells, which may indirectly affect microvillus assembly. Additionally, the ARHGAP18-ezrin module regulates RhoA activity to control the assembly of distinct actin-based structures, providing a molecular mechanism for negative regulation. This article provides a comprehensive overview of GO:1903697, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental models. It is intended for researchers seeking to investigate this process using CRISPR-based gene editing and other advanced technologies.

GO:1903697, negative regulation of microvillus assembly, is a biological process defined as any process that stops, prevents, or reduces the frequency, rate, or extent of microvillus assembly. Microvillus assembly itself is the aggregation, arrangement, and bonding of components to form a microvillus, a specialized actin-based membrane protrusion. Negative regulation can occur at multiple levels, including inhibition of actin polymerization, disruption of ERM protein activation, or downregulation of key structural components. This term encompasses both direct inhibition of assembly machinery and indirect processes that lead to reduced microvillus formation.

Negative regulation of microvillus assembly is critical for controlling epithelial cell surface architecture and function. Microvilli are essential for nutrient absorption, secretion, and cell signaling, and their improper regulation can lead to diseases such as cancer, inflammatory bowel disease, and developmental disorders. Understanding the molecular mechanisms that negatively regulate microvillus assembly can provide insights into how cells maintain tissue homeostasis and how dysregulation contributes to pathology. Moreover, this process is a potential target for therapeutic intervention in diseases characterized by abnormal microvillus formation or loss.

The following genes and proteins are involved in the negative regulation of microvillus assembly, based on published literature.

Negative regulation of microvillus assembly is controlled by multiple signaling pathways. The RhoA-ARHGAP18-ezrin autoregulatory module is a central mechanism: ARHGAP18 inactivates RhoA, leading to reduced actin polymerization and microvillus disassembly. Cyclic AMP-dependent protein kinase A (PKA) negatively modulates adherens junction integrity and intestinal epithelial differentiation, which can indirectly inhibit microvillus assembly. Additionally, NHERF1 and IRBIT regulate Na+/H+ exchanger 3 activity, influencing intracellular pH and membrane dynamics that may affect microvillus formation. These pathways integrate developmental and environmental cues to fine-tune microvillus assembly.

Dysregulation of microvillus assembly is associated with cancer progression. Loss of microvilli and altered expression of ERM proteins are observed in various carcinomas, contributing to increased cell motility and invasion. The ARHGAP18-ezrin module, which regulates RhoA and actin dynamics, has been implicated in cancer cell migration and metastasis. Targeting negative regulators of microvillus assembly could provide therapeutic strategies to inhibit tumor spread.

In inflammatory bowel disease (IBD), disruption of intestinal epithelial barrier function is a key feature. Microvillus atrophy and altered expression of microvillus components are observed in IBD patients. PKA-mediated negative regulation of intestinal epithelial differentiation may contribute to barrier dysfunction. Understanding how microvillus assembly is negatively regulated could lead to new treatments for IBD.

Microvillus inclusion disease is a rare congenital disorder characterized by severe diarrhea and loss of microvilli in the intestine. While the primary defect is in MYO5B, negative regulation of microvillus assembly may play a role in disease pathogenesis. Studies on NHERF1 and IRBIT interactions with ion transporters suggest that disrupted membrane dynamics can affect microvillus formation.

Live-cell imaging using fluorescently tagged actin or ezrin allows real-time visualization of microvillus dynamics. This method can capture the disassembly of microvilli following negative regulatory signals, such as ARHGAP18 activation or PKA stimulation [1,4].

Proximity labeling or immunoprecipitation coupled with mass spectrometry can identify protein complexes involved in negative regulation. For example, the ARHGAP18-ezrin interaction was elucidated using biochemical and proteomic approaches.

Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate microvillus assembly. Cells with altered microvilli can be sorted by flow cytometry using microvillus markers, and sgRNA enrichment analyzed by sequencing.

RNA-seq can reveal changes in gene expression associated with negative regulation of microvillus assembly. For instance, PKA activation alters the expression of differentiation markers and microvillus components in intestinal epithelial cells.

Researchers studying negative regulation of microvillus assembly-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR gene editing services to accelerate functional validation and therapeutic development.

Negative regulation of microvillus assembly (GO:1903697) is a critical biological process that controls epithelial cell surface architecture and function. Key regulators such as ARHGAP18, ezrin, and PKA signaling pathways modulate actin dynamics and membrane anchoring to inhibit microvillus formation. Dysregulation of this process is associated with cancer, inflammatory bowel disease, and developmental disorders. Advances in CRISPR gene editing and imaging technologies are enabling detailed mechanistic studies and potential therapeutic targeting. EDITGENE provides comprehensive services to support research in this field.